# Foghorn Therapeutics Inc.: Form 8-K, filed Mar 9, 2023

- Company: [Foghorn Therapeutics Inc.](/companies/fhtx.md) (CIK 1822462)
- Form: 8-K
- Filed: 2023-03-09
- Accepted by EDGAR: Mar 9, 2023, 12:12 ET
- Period: 2023-03-07
- Accession: 0001628280-23-007139
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1822462/000162828023007139/fhtx-20230307.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1822462/000162828023007139/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1822462/000162828023007139/fhtx-20230307.htm

Filed Mar 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-007139. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.